• Anthropic PBC (NASDAQ:ANT) fell from a $115.10 high on Nov 19 to an $83.15 low on Nov 20, a 27% drop in 2 sessions.
  • Underwriters fully exercised their option on 147 million extra shares, so the overallotment short that normally funds a price-support bid is already closed.
  • The Dec 15 lockup step makes up to 303 million shares, about $25.1 billion at $83, eligible for sale. That is about 5 times Bloomberg Intelligence’s $4.6 billion Nasdaq-100 buying estimate.
  • SpaceX, the last mega-IPO, first closed below its IPO price 5 weeks after listing and bottomed 22% lower before recovering.

Anthropic PBC (NASDAQ:ANT) is trading within cents of its $83 IPO price after one of the fastest reversals ever seen in a mega-listing.

The stock opened at $111.50 on Nov 19 and hit $115.10 intraday. It then closed at $97.17, up 17% on the day. On Friday, however, the selling resumed. Shares opened at $89.86 and fell to a low of $83.15. That is a 27% drop from the high in under 2 trading days.

The timing made it worse. The S&P 500 and the Dow both entered correction territory on Friday, and the Nasdaq Composite turned negative for 2026. As a result, the largest IPO on record is now trading as a high-beta proxy for the whole AI trade.

Most coverage now treats $83 as “support” simply because it is the IPO price. That assumption deserves a closer look. The deal mechanics suggest the usual safety net is already gone.

Candlestick chart of Anthropic (ANT) stock’s first 2 sessions. It fell from a $115.10 high on Nov 19 to an $83.15 low on Nov 20, just above the $83 IPO price. Fibonacci levels are marked at $102.84, $99.05 and $95.26.
Chart 1: Anthropic gave back its entire IPO pop in 2 sessions. Day 2 is intraday as of about 12:50 p.m. ET, Nov 20.

How The Greenshoe Removed The Bodyguard

In a typical IPO, underwriters sell more shares than the base deal. Anthropic’s base offering was 980 million shares, and the pricing release granted the banks a 30-day option on 147 million more. That extra 15% creates a short position for the syndicate.

The short then becomes a tool. If the stock trades below the offer price, underwriters buy shares in the open market to cover it. 

That buying is the familiar “stabilization bid,” and it is permitted under SEC Regulation M, Rule 104. If the stock trades above the offer, the banks simply exercise the option and buy the extra shares from the company at $83.

Anthropic’s closing announcement confirmed the second path. The deal closed at 1.127 billion shares, including full exercise of the 147 million-share option. Gross IPO proceeds reached about $93.5 billion, or about $119.5 billion including a concurrent $26 billion private placement.

That detail matters for anyone treating $83 as a floor. Full exercise means the syndicate covered its short through the option. 

Consequently, there is no remaining short position that obliges the banks to buy shares on a dip. Stabilization is still legally possible during the window, but the economic reason to do it is gone.

In plain terms, $83 is now a psychological level, not a defended one.

The Float Math Works Against A Quick Bounce

Anthropic sold 1.127 billion shares against roughly 13.1 billion shares outstanding. That puts the IPO float near 8.6%. Under the registration filings on SEC EDGAR, non-founder employees could also sell up to 10% of their holdings from day one, about 315 million shares. 

Together, roughly 1.44 billion shares, or about 11% of the company, can trade today. A small float usually supports a new issue. 

Here, though, turnover was extreme. More than 846 million shares changed hands on day one, equal to about 75% of the entire IPO. In other words, much of the first-day buying came from fast money, and fast money leaves fast.

The supply calendar is also front-loaded. The staggered lockup in the S-1/A releases up to 303 million shares on Dec 15, another 303 million on Jan 5, 353 million on Jan 19, and 353 million on Feb 2. The Dec 15 step alone is worth about $25.1 billion at $83.

By comparison, Bloomberg Intelligence estimates about $4.6 billion of buying from Nasdaq-100 trackers under the index’s fast-entry rule. 

Broader estimates of first-month passive demand run near $19 billion. Either way, potential supply on a single unlock date exceeds the best-known source of mechanical demand.

Bar chart comparing $25.1 billion of Anthropic shares eligible for sale on Dec 15 with $19 billion of estimated passive demand and $4.6 billion of estimated Nasdaq-100 index buying.
Chart 2: The Dec 15 unlock alone outweighs Nasdaq-100 buying about 5 to 1. Eligible shares are a ceiling, not a sales forecast.

What Happened To Mega-IPOs That Broke Issue

History offers three useful templates.

SpaceX (2026). SpaceX (NASDAQ:SPCX) priced at $135 in June, closed day one at $161 and hit $225.64 intraday on June 16. It joined the Nasdaq-100 on July 7, yet the index buying did not stop the slide. The stock first closed below its IPO price on July 16 at $131.11 and bottomed at $104.83 on Aug 3, about 22% under issue. It then recovered after its first lockup expiry and closed at $162.57 on Oct 9.

Meta Platforms (2012). Facebook priced at $38, closed its first session at $38.23 and broke issue on day 2. It went on to bottom near $17.55 in September 2012, more than 50% below the offer, before becoming one of the best-performing large caps of the following decade.

Uber Technologies (2019). Uber priced at $45 and closed its first day at $41.57, below issue from the start.

The pattern is consistent. Breaking the IPO price says more about positioning and supply than about the business. Even so, the drawdowns that follow can be deep. Notably, SpaceX’s slide happened after index inclusion, which suggests passive demand gets priced in early.

Line chart of SpaceX (SPCX) after its $135 IPO. It peaked at $225.64 in June, first closed below its IPO price on July 16, hit a $104.83 low on Aug 3 and recovered to $162.57 by Oct 9.
Chart 3: SpaceX broke issue 5 weeks after listing, bottomed 22% lower, then recovered.

Where The Real Floors Are

If the IPO price is not defended, then the next 4 weeks of share flows matter more than the $83 line. Six dated events stand out.

Date Event Likely effect on ANT
Nov 23 Listed options open; Tradr 2x long (ANTT) and 2x short (ANTZ) ETFs begin trading on Cboe Dealer hedging can amplify moves either way
Nov 30 Nasdaq-100 fast-entry ranking date under the index methodology Confirms or delays passive demand
Dec 9 Federal Reserve decision, with markets pricing a hike Higher rates pressure long-duration growth stocks
About Dec 14 Underwriter quiet period ends; syndicate analysts can initiate Bullish initiations are customary, but not guaranteed
Dec 15 First scheduled lockup step, up to 303 million shares The largest single supply event of the year
Dec 18 to 21 Triple witching, then Nasdaq-100 inclusion at the Dec 21 open Index buying, likely partly front-run

The options launch deserves attention first. Listed options and leveraged ETFs bring hedging flows that can turn a slow drift into a fast move. If puts dominate early, dealers hedging those positions may sell into weakness. If calls dominate, the reverse can trigger a squeeze.

After that, the quiet-period expiry is the strongest potential support. Syndicate banks rarely initiate with Sell ratings on their own deals. 

Still, several independent firms have already published views, ranging from a Morningstar fair value near $92 to Buy targets of $150 to $155 from Needham and Melius.

Is ANT Cheap At $83? The Valuation Check

The business case remains extraordinary. According to the amended S-1, Anthropic generated $16.96 billion of revenue in the third quarter of 2026, up 1,127% from a year earlier and 47% from the second quarter. Trailing 12-month revenue stands near $35.3 billion.

However, the margin picture moved the wrong way. Anthropic swung from a $974 million operating profit in Q2 to a $567 million operating loss in Q3. 

Compute and infrastructure costs rose to 58% of revenue from 48%, partly because the company bought pricier short-term capacity. It also carries roughly $895 billion of compute and infrastructure commitments.

Valuation lens (at about $83 to $84) Multiple
Trailing 12-month sales, basic share count (about $1.1 trillion market cap) About 31x
Q3 revenue annualized ($67.8 billion), fully diluted value near $1.5 trillion About 22x
Consensus 2027 revenue near $128 billion, fully diluted About 12x

So the answer depends on the time frame. On trailing numbers, ANT is priced like a scarce asset. On 2027 estimates, the multiple compresses quickly, provided growth holds and margins recover. That proviso is exactly what a market in correction is now questioning.

The competitive read-through also cuts both ways. Michael Burry recently argued that Anthropic is taking enterprise share from Palantir Technologies (NASDAQ:PLTR). Yet that same disruption story raised the bar Anthropic must clear every quarter.

ANT Technical Levels And 3 Scenarios To Dec 21

Two sessions of data cannot support moving averages, RSI, or MACD. Those indicators need weeks of history. Instead, the reliable levels come from the IPO itself and from a Fibonacci retracement of the $83 to $115.10 range.

Level Price Why it matters
Day-1 high $115.10 The top of the debut; heavy trapped supply
Fib 38.2% $102.84 First retracement target on any squeeze
Fib 50% $99.05 Midpoint of the IPO range
Day-1 close $97.17 Reclaiming it would erase Friday’s damage
Fib 61.8% $95.26 Deep retracement; often the last pivot before a trend resumes
Day-1 low $92.72 First overhead resistance after the break
IPO price $83.00 Psychological level, no longer defended by a syndicate short

From there, three paths are plausible into Nasdaq-100 entry on Dec 21.

Bull case: reclaim $97.17. Options open with call demand, the Dec 9 Fed decision lands as expected, and syndicate initiations around Dec 14 reset sentiment. A close back above $92.72 would turn the day-1 low into support, with $97.17 and $99.05 as the next tests.

Base case: chop between $83 and $92.72. The stock trades around the IPO price, absorbs the Dec 15 unlock, and drifts higher into index buying. This path fits a market that is still in correction but no longer panicking.

Bear case: a SpaceX-style break. A close below $83 removes the last psychological anchor. If ANT follows the SpaceX template, a drawdown of about 20% would put the stock near $66 around the Dec 15 unlock, before index demand arrives.

Scenario chart of 3 illustrative paths for Anthropic stock from Nov 20 to its Dec 21 Nasdaq-100 entry. The bull path reclaims $97.17, the base path trades between $83 and $92.72, and the bear path falls about 20% to near $66.
Chart 4: 3 illustrative paths into Nasdaq-100 entry. Scenario map, not a forecast.

For traders, the first signal comes early. Watch the put-to-call mix when options open on Nov 23, and watch whether ANT can close above $83 on Monday. Two consecutive closes below the IPO price would favor the bear path.

The Bottom Line For ANT Investors

Bulls have a real case. Anthropic is growing revenue more than tenfold a year; it has index demand arriving on Dec 21, and analyst coverage starts in mid-December. A small float can also cut both ways and spark sharp rallies.

Bears have a case too. The underwriters’ short is closed, a $25 billion unlock lands in less than 4 weeks, margins turned negative in Q3, and the broader market is in correction. Moreover, SpaceX showed that index inclusion can mark a local top rather than a floor.

The practical takeaway is simple. Treat $83 as a reference point, not a guarantee. The flows calendar, not the IPO price, is likely to decide where ANT trades by year-end.

Why is Anthropic stock falling? 

ANT fell 27% from its $115.10 high in 2 sessions as the S&P 500 and Dow entered a correction, AI stocks sold off, and early buyers took profits from the IPO pop.

What was Anthropic’s IPO price

Anthropic priced its IPO at $83 per share on Nov 18, 2026, above the $70 to $78 range, and began trading on Nasdaq under ANT on Nov 19.

Will underwriters defend the $83 IPO price?

Unlikely in size. Underwriters fully exercised their 147 million-share over-allotment option, which closes the short position normally used to buy shares below the offer price.

When does the Anthropic lockup expire? 

The lockup is staggered. Up to 303 million shares become eligible on Dec 15, with further steps on Jan 5, Jan 19, and Feb 2, 2027.

When does Anthropic join the Nasdaq-100?

ANT is expected to join at the Dec 21 open under the fast-entry rule, pending Nasdaq’s announcement.

Benzinga Disclaimer: This article is from an unpaid external contributor. It does not represent Benzinga’s reporting and has not been edited for content or accuracy.